| 29th Nov 2018 7:00 am |
GNW |
Rule 2.9 Announcement |
| 28th Nov 2018 4:12 pm |
RNS |
Form 8.3 - Takeda Pharmaceutical Company Limited |
| 28th Nov 2018 3:48 pm |
RNS |
Form 8.5 (EPT/RI)- Shire plc AMENDMENT |
| 28th Nov 2018 3:28 pm |
RNS |
Form 8.3 - Takeda Pharmaceutical Company Limited |
| 28th Nov 2018 3:25 pm |
RNS |
Form 8.3 - Shire Plc |
| 28th Nov 2018 3:23 pm |
RNS |
Form 8.3 - Shire plc |
| 28th Nov 2018 3:20 pm |
RNS |
Form 8.3 - Shire plc |
| 28th Nov 2018 3:01 pm |
RNS |
Form 8.5 (EPT/NON-RI) |
| 28th Nov 2018 2:49 pm |
RNS |
Form 8.5 (EPT/RI) - Replacement of Shire plc |
| 28th Nov 2018 2:41 pm |
RNS |
Form 8.3 - Takeda Pharmaceutical Company Limited |
| 28th Nov 2018 2:40 pm |
BUS |
Form 8.3 - SHIRE PLC AMENDMENT |
| 28th Nov 2018 2:40 pm |
BUS |
Form 8.3 - SHIRE PLC AMENDMENT |
| 28th Nov 2018 2:39 pm |
RNS |
Form 8.3 - Shire plc |
| 28th Nov 2018 2:39 pm |
BUS |
Form 8.3 - SHIRE PLC AMENDMENT |
| 28th Nov 2018 2:38 pm |
RNS |
Form 8.5 (EPT/NON-RI) |
| 28th Nov 2018 2:00 pm |
RNS |
Form 8.3 - Shire plc |
| 28th Nov 2018 1:55 pm |
RNS |
Form 8.3 - Takeda Pharmaceutical Company Limited |
| 28th Nov 2018 1:55 pm |
RNS |
Form 8.3 - Shire plc |
| 28th Nov 2018 1:48 pm |
RNS |
Form 8.3 - Shire plc |
| 28th Nov 2018 1:38 pm |
BUS |
Form 8.3 - SHIRE PLC - Amendment |
| 28th Nov 2018 1:20 pm |
RNS |
Form 8.3 - Takeda Pharmaceutical Company Limited |
| 28th Nov 2018 1:17 pm |
RNS |
Form 8.3 - Shire Plc |
| 28th Nov 2018 12:43 pm |
BUS |
FORM 8.3 - SHIRE PLC - AMENDMENT |
| 28th Nov 2018 12:05 pm |
BUS |
Form 8.3 - SHIRE PLC |
| 28th Nov 2018 11:57 am |
RNS |
Form 8.5 - Shire Plc |
| 28th Nov 2018 10:53 am |
BUS |
Form 8.3 - SHIRE PLC - AMENDMENT |
| 28th Nov 2018 10:48 am |
RNS |
Form 8.5 (EPT/RI)- Shire plc |
| 28th Nov 2018 10:46 am |
RNS |
Form 8.5 (EPT/NON-RI)- Shire Plc |
| 28th Nov 2018 10:33 am |
RNS |
Form 8.5 (EPT/RI) |
| 28th Nov 2018 10:31 am |
RNS |
Form 8.5 (EPT/NON-RI) - SHIRE PLC |
| 28th Nov 2018 10:30 am |
RNS |
Form 8.5 (EPT/RI) - SHIRE PLC |
| 28th Nov 2018 10:27 am |
RNS |
Form 8.5 (EPT/RI) - SHIRE PLC |
| 28th Nov 2018 10:25 am |
RNS |
Form 8.5 (EPT/RI) - SHIRE PLC |
| 28th Nov 2018 10:22 am |
RNS |
Form 8.5 (EPT/RI) |
| 28th Nov 2018 9:48 am |
RNS |
Form 8.3 - Shire Plc |
| 28th Nov 2018 8:42 am |
PRN |
Form 8.3 - Shire PLC |
| 28th Nov 2018 7:00 am |
RNS |
Form 8.3 - Shire PLC |
| 27th Nov 2018 4:47 pm |
RNS |
Form 8.3 - Shire plc |
| 27th Nov 2018 4:46 pm |
RNS |
Form 8.3 - Takeda Pharmaceutical |
| 27th Nov 2018 4:30 pm |
GNW |
Shire plc: JAMA Publishes Complete Results of Phase 3 HELP Study™ Evaluating Lanadelumab as a Preventive Treatment for Hereditary Angioedema |
